878 A multi-centre study evaluating performance of multidisciplinary teams: Urology vs the top cancer killers

Do multidisciplinary cancer care teams suffer decision-making fatigue: an observational, longitudinal team improvement study

“…To date, evidence has documented high workloads on cancer MDTs with meetings up to 5 hours reported in the recent Cancer Research UK report 5. For example, in the UK, studies have reported that a breast cancer MDT reviewed between 29 and 51 patients with the meeting often running for up to 3.5 hours1; lung MDT between 22 and 30 patients with meetings up to 3 hours2; urology MDT between 19 and 51 patients with meetings up to 2 hours3 and a colorectal MDT between 9 and 55 patients with meetings up to 1 hour and 40 min 4. High workloads and prolonged periods of consecutive decision-making (DM) in the meetings have become a norm for many teams,6 8 something that is likely to continue as teams are trying to maximise productivity in the face of increasing numbers of new cancer cases worldwide,19 20 rising financial pressures20 21 and growing staff shortages 22…”

Do multidisciplinary cancer care teams suffer decision-making fatigue? An observational, longitudinal team improvement study

“…Here, patients are reviewed and treatment recommendations are agreed on by the team in a sequential manner for up to a few hours at a time. [1][2][3][4][5][6][7][8][9] While the MDT approach to cancer care is endorsed widely, 7 evidence of its effectiveness is unclear and variable. [8][9][10][11][12][13][14][15][16][17] A pattern generally observed in MDT meetings is unequal participation to discussion and suboptimal sharing of information.…”